Form 4 for DYN Dyne Therapeutics, Inc.
Accepted 2021-07-15 00:00:00 ET · period of report 2021-07-13 · accession 0001209191-21-046784 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-07-15 | 2021-07-13 | DYN | Atlas Venture Fund XI, L.P. | 10% | J - Other | $0.00 | -814.0K | 7.33M | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-13 | J | D | 814,013 | $0.00 | 7,326,117 | D | — | — |